LBA33A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC). (23rd October 2018) - Hoimes, C J; Albany, C; Hoffman-Censits, J; Fleming, M T; Trabulsi, E; Picus, J; Cary, C; Koch, M O; Walling, R; Kelly, W; Godwin, J L; Cooney, M; et al.